-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Ayala Pharmaceuticals, Inc. quarterly/annual Revenues history and growth rate from Q1 2017 to 2023.
- Ayala Pharmaceuticals, Inc. Revenues for the quarter ending June 30, 2023 was $9K, a 76.3% decline year-over-year.
- Ayala Pharmaceuticals, Inc. Revenues for the twelve months ending June 30, 2023 was $209K.
- Ayala Pharmaceuticals, Inc. annual Revenues for 2023 was $13K, a 98.1% decline from 2022.
- Ayala Pharmaceuticals, Inc. annual Revenues for 2022 was $692K.
- Ayala Pharmaceuticals, Inc. annual Revenues for 2018 was $6.06M, a 49.6% decline from 2017.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)